SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period › Research Explorer

DOI

https://doi.org/10.1016/S2665-9913(22)00221-1
Final published version

Laura Boekel
Yaëlle R. Besten
Femke Hooijberg
Maurice Steenhuis
Maureen Leeuw
Sadaf Atiqi
Willem F. Lems
Alexandre E. Voskuyl
Martijn Gerritsen
Charlotte Krieckaert
Maarten Boers
Mike T. Nurmohamed

Original language	English
Pages (from-to)	e747-e750
Journal	The Lancet Rheumatology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1016/S2665-9913(22)00221-1
Publication status	Published - 1 Nov 2022

ID: 26637398